Managing Implantable Cardioverter-Defibrillators at End-of-Life: Practical Challenges and Care Considerations
- PMID: 30665495
- DOI: 10.1016/j.amjms.2018.11.016
Managing Implantable Cardioverter-Defibrillators at End-of-Life: Practical Challenges and Care Considerations
Abstract
Implantable cardioverter-defibrillators (ICDs) monitor for and terminate malignant arrhythmias. Given their potential as a life-saving therapy, an increasing number of people receive an ICD every year, and a growing number are currently living with ICDs. However, cardiopulmonary arrest serves as the final common pathway of natural death, and the appropriate management of an ICD near the end-of-life is crucial to ensure that a patient's death is not marked by further suffering due to ICD shocks. The tenets of palliative care at the end-of-life include addressing any medical intervention that may preclude dying with dignity; thus, management of ICDs during this phase is necessary. Internists are at the forefront of discussions about end-of-life care, and are likely to find discussions about ICD care at the end-of-life particularly challenging. The present review addresses issues pertaining to ICDs near the end of a patient's life and their potential impact on dying patients and their families. A multidisciplinary, patient-centered approach can ensure that patients receive the maximum benefit from ICDs, without any unintended pain or suffering.
Keywords: Goals of care; Informed decision-making; Palliative care.
Copyright © 2018. Published by Elsevier Inc.
Similar articles
-
Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.J Med Ethics. 2013 Feb;39(2):94-7. doi: 10.1136/medethics-2012-100613. Epub 2012 Nov 8. J Med Ethics. 2013. PMID: 23139392
-
Guidelines on the management of implantable cardioverter defibrillators at the end of life.Rev Clin Esp (Barc). 2014 Jan-Feb;214(1):31-7. doi: 10.1016/j.rce.2013.08.009. Epub 2013 Oct 10. Rev Clin Esp (Barc). 2014. PMID: 24119393 English, Spanish.
-
Implantable Cardiac Defibrillator Deactivation During End-of-Life Care in the COVID-19 Pandemic.J Am Board Fam Med. 2021 May-Jun;34(3):474-476. doi: 10.3122/jabfm.2021.03.200536. J Am Board Fam Med. 2021. PMID: 34088806
-
Deactivation of implantable cardioverter-defibrillators at end of life.Future Cardiol. 2013 Nov;9(6):885-96. doi: 10.2217/fca.13.81. Future Cardiol. 2013. PMID: 24180544 Review.
-
Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.Clin Geriatr Med. 2012 Nov;28(4):693-702. doi: 10.1016/j.cger.2012.07.005. Clin Geriatr Med. 2012. PMID: 23101578 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical